Atheroembolic renal disease associated with dabigatran overdose

Mayo RR, Swartz RD (1996) Redefining the incidence of clinically detectable atheroembolism. Am J Med 100(5):524–529 Scolari F, Tardanico R, Zani R et al (2000) Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 36:1089–1109 Modi KS, Rao VK (2001) Atheroembolic renal disease. J Am Soc Nephrol 12(8):1781–1787 Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A, Cholesterol Embolism Study (CHEST) Investigators (2003) The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 42(2):211–216 Bashore TM, Gehrig T (2003) Cholesterol emboli after invasive cardiac procedures. J Am Coll Cardiol 42(2):217–218 Blankenship JC, Butler M, Garbes A (1995) Prospective assessment of cholesterol embolization in patients with acute myocardial infarction treated with thrombolytic vs conservative therapy. Chest 107:662–668 Schwarz MW, McDonald GB (1987) Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction. JAMA 258:1934–1935 Wong FK, Chan SK, Ing TS, Li CS (1995) Acute renal failure after streptokinase therapy in a patient with acute myocardial infarction. Am J Kidney Dis 26:508–510 Meyrier A (2006) Cholesterol crystal embolism: diagnosis and treatment. Kidney Int 69:1308–1312